BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
219 hedge funds and large institutions have $3.78B invested in Blueprint Medicines in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 56 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 29
0% less funds holding
Funds holding: 220 → 219 (-1)
19% less capital invested
Capital invested by funds: $4.68B → $3.78B (-$898M)
Holders
219
Holding in Top 10
8
Calls
$90.8M
Puts
$29.4M
Top Buyers
| 1 | +$65.8M | |
| 2 | +$18.4M | |
| 3 | +$17.2M | |
| 4 |
HM
HealthCor Management
New York
|
+$16.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.5M |
Top Sellers
| 1 | -$24.2M | |
| 2 | -$23.8M | |
| 3 | -$20.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$17.9M |
| 5 |
AG
Artal Group
Luxembourg
|
-$11M |